>>> Canadian Oil Sands could receive takeover offer from JV partner

Canadian Oil Sands could receive takeover offer from JV partner 

Canadian Oil Sands saw its stock price climb 20% on Monday on the heels of speculation that the Calgary, Alberta-based company could end up being on the receiving end of a takeover bid by one of its Syncrude Canada partners, reported The National Post on 3 February.

A report from the newspaper's Financial Post section cited First Energy Capital analyst Michael Dunn as saying that Canadian Oil Sands may, should its stock continue to under perform, very well be bought by one of its partners in the joint venture involving seven energy firms.

According to the report, Canadian Oil Sands, with a 37% stake in Syncrude, has the largest position in the JV. Imperial Oil, meanwhile, has a 25% interest. An earlier report from this news service noted that the other partners include Suncor (12%), and SINOPEC (9%), Nexen Oil Sands (7%), Mocal Energy (5%) and Murphy Oil (5%).

While Imperial Oil opted not to comment on the speculation, parent company ExxonMobil of Irving, Texas indicated on Monday that it wants to take advantage of low oil prices by seeking out M&A opportunities.

Canadian Oil Sands' market cap is CAD 3.84bn (USD 3.051bn).

National Post

(Exane) Reckitt : Take out, take in, please see within

* A well-loved stock with two bull angles
RB is a very well-loved stock. Leaving optimism on near-term trading prospects aside, as we see it there are two main strands to the bull case: (i) RB gets acquired for its consumer healthcare business & (ii) it further morphs into a consumer healthcare play. In this note we explore each of these bull angles.

* A bid is already more than reflected in the valuation
While we view it as unlikely, we concede that it is not impossible that RB falls prey to a bid from either pharma or consumer majors. However to our mind this is more than in the price. Applying 21x CY15e EBITDA to Health (the take-out multiple for hotly contested Merck consumer healthcare), the remainder of Reckitt reverses out at c.15x (a material premium to Beiersdorf, Colgate, Estee Lauder and L’Oreal). In addition, let us not forget that RB has been so efficiently run that any acquisition synergies are likely to be somewhat offset by reinvestment to align the
business to acquirer practices. Finally, let us not forget the unique RB culture.

* Acquisitions will necessitate lowering the quality bar and raising the price bar
Picking up the other bull angle, while there are acquisition options for RB, quality assets are now few and far between (indeed, there are possibly no material quality assets available for sale). To acquire, RB will very likely have to lower its quality bar and raise its price bar.

* Yes near-term Health trading will be solid, but challenges lie ahead
That a good flu season is upon us is no secret, but challenges lie ahead: Mucinex generics, Nexium across Europe, Perrigo entering Europe.

* We get the story, but to us it feels more than in the price
c.25x CY15e P/E for a business with c.7-8% momentum earnings growth and to which the market sentiment is overwhelmingly positive. We reiterate our Underperform rating.

(BFW) Reckitt Takeover Not Impossible, Captured in Valuation: Exane


Reckitt Takeover Not Impossible, Captured in Valuation: Exane
2015-02-03 08:59:33.420 GMT


By Heather Burke
(Bloomberg) -- Exane says it isn’t impossible Reckitt could
get a bid from either a big pharmaceutical or consumer co.
although such probability is “more than in the price,”
according to note.
* Sees offer as unlikely as co. is big, very efficient, has
significant mid-term challenges in its Health unit
* Consumer health care industry is fragmented, consolidating
* Significant, quality acquisition targets for Reckitt
“scarce”
* Co. would probably have to “lower its quality bar and
raise its price bar”
* Co. would probably have to “lower its quality bar and
raise its price bar”</li></ul>
* Reiterates underperform, PT 4,700p
* Next catalyst: 2014 earnings Feb. 11


For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
Heather Burke in London at +44-20-3525-2044 or
hburke2@bloomberg.net
To contact the editors responsible for this story:
James Ludden at +44-20-3525-2645 or
jludden@bloomberg.net
Jurjen van de Pol

(Citi) What Works in Equity Markets : QE, GDP Growth and the Value Conundrum

What Works in Equity Markets
QE, GDP Growth and the Value Conundrum
* Value = Key Macro Risk Diversifier — Of all our style composites, only Value appears to offer any diversification at present from a macro risk perspective.
* QE + Nominal GDP Growth Put = Good for Value — Historically, Value offers statistically significant average returns in excess of 1% when the street increases its year-on-year GDP growth forecast.
* Cheap != Cheap — Value does not look attractive on valuations. Relative to the benchmark, not only are cheap stocks trading around all-time highs, but expensive stocks are also trading around all-time lows.
* Value = Cyclical + Financials vs. Defensives — In the absence of sector neutrality, to be long Value at this point means essentially taking significant cyclical bias on Financials and Energy. Risk remains highly levered to Financials
* QE + De-Equitisation = Good for Value; but Prefer Defensive (Income) Over Cyclical — Our strategists suggest QE should benefit de-equitisers. This should in turn be a tailwind for Dividend Yield and companies returning capital to
shareholders.
* Stock Screen: Defensive Value & Quality at a Reasonable Price — We present a screen looking for potentially undervalued stocks in our High Quality portfolio and overlay this with defensive Value (income). 10 stocks pass the screen. Large Caps include: Snam, SEB, Next, WPP, Red Electrica.

>>> Remy Cointreau Exchangeable bond - Press Release attached

ORPAR, a holding company controlled by the Dubreuil family, said in a statement it will offer an initial EU150M ($170M) of bonds exchangeable into Remy Cointreau shares.
  • Sale can be increased to EU200M
  • 80% of the proceeds will be used to purchase Remy Cointreau shares on the market
  • Bonds to have implied exchanged price of 27.5% to 32.5%over the reference price of Remy Cointreau shares
  • Bonds are due July 2019
  • HSBC is global coordinator and bookrunner.

(BFW) Altice Managers to Buy 4.4m Shrs From Carlyle Cable

Carlyle +Cinven had a 6.9% stake in ATC with a lock up ending on the 19th of Feb.

after that transaction, they will stay with 5.1% stake

Press Release :

Altice announces agreement by Executives to buy shares in Altice S.A. from
Carlyle

 

February 2, 2015 - Altice S.A. (Euronext: ATC) today announced that certain
executives and senior managers of Altice S.A. and their affiliates ("The
Altice Managers") have reached an agreement ("The Sale") with Carlyle Cable
Investments SC ("Carlyle") whereby Carlyle will sell some of its ordinary
shares in Altice S.A. ("Altice") to The Altice Managers.

 

Carlyle has agreed to sell 4.4 million ordinary shares in Altice equivalent to
approximately 1.8% of Altice's ordinary share capital. Entities controlled by
Patrick Drahi, Dexter Goei and Patrice Giami are acquiring respectively 4.16
million shares, 200,000 shares and 40,000 shares.

 

Exclusively for the purpose of this transaction, J.P. Morgan Securities plc
and Goldman Sachs International have agreed to a partial waiver of the lock u

agreement entered into by Carlyle in connection with its sale of ordinary
shares in Altice on November 17, 2014 and due to expire on February 15, 2015.
Any ordinary shares in Altice owned by Carlyle and not part of The Sale will
remain subject to the terms of the aforementioned lock up agreement. For the
avoidance of doubt, the scope and terms of said lock up agreement remain
strictly unchanged unless explicitly mentioned otherwise in this press
release.

Altice Managers to Buy 4.4m Shrs From Carlyle Cable
2015-02-02 16:52:21.381 GMT


By Jim Silver
(Bloomberg) -- Shrs equal 1.8% stake, Altice says.
* Entities controlled by Chairman Patrick Drahi, CEO Dexter
Goei and Patrice Giami are buying 4.16m shrs, 200k shrs, 40k
shrs, respectively

Statement:Link
Link to Company News:ATC NA <Equity> CN <GO>

For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the editor responsible for this story:
Jim Silver at +1-212-617-7342 or
jsilver@bloomberg.net

(BofA-ML) European Sector Signal - Feb 2015 : Long cons. Avoid Bks & Late cyc.


* Long consumers - avoid Banks and late-cycle sectors
The bullish stances on Personal & Household Goods, Travel & Leisure and Media
are maintained from last month, as are the bearish signals in Banks and late-cycle
sectors. Average beta of ‘Bullish’ signals equals one; it had previously been <1
since Nov ’13. In contrast, ‘Bearish’ sectors remain cyclically biased – this will
continue until our Style Cycle signals ‘Recovery’ in Europe. Extremely low bond
yields and weak commodity prices keep any macro risk-appetite in check.

* Best monthly performance since inception
January was the strongest month for our Sector Signals model since inception in
June ’13. ‘Bullish’ sectors outperformed ‘Bearish’ sectors by 3.7% last month (see
Table 3). We attribute this to the importance of momentum factors in our sectorpicking
framework.

* Following the momentum
Longs are maintained in consumer sectors with strong price momentum: Personal &
Household Goods, Travel & Leisure and Media. Our core theme of avoiding Banks
and late-cycle cyclicals (Industrials and Construction) will remain in the absence of
persistent macro improvement. Poor earnings revisions, poor price momentum and
cyclical characteristics keep Oil & Gas at the bottom, despite lack of fund manager
positioning in the sector.